{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "11",
                "@year": "2023",
                "@timestamp": "2023-07-11T23:10:09.000009-04:00",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2019",
                "@month": "04"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-addon-generated-timestamp": "2019-06-05T21:26:37.301Z",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/car"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60028590",
                            "@country": "usa",
                            "city": "St. Louis",
                            "organization": [
                                {"$": "School of Medicine"},
                                {"$": "Saint Louis University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028590",
                                "@dptid": "104446895"
                            },
                            "state": "MO",
                            "ce:source-text": "1School of Medicine, Saint Louis University, St. Louis, Missouri, USA",
                            "@dptid": "104446895"
                        },
                        "author": [{
                            "ce:given-name": "Sharon E.",
                            "preferred-name": {
                                "ce:given-name": "Sharon E.",
                                "ce:initials": "S.E.",
                                "ce:surname": "Frey",
                                "ce:indexed-name": "Frey S.E."
                            },
                            "@seq": "1",
                            "ce:initials": "S.E.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Frey",
                            "@auid": "34975079200",
                            "ce:indexed-name": "Frey S.E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "122642906",
                            "@country": "aus",
                            "city": "Adelaide",
                            "organization": {"$": "CMAX Clinical Research Pty Ltd."},
                            "affiliation-id": {"@afid": "122642906"},
                            "state": "SA",
                            "ce:source-text": "2CMAX Clinical Research Pty Ltd., Adelaide, SA, Australia"
                        },
                        "author": [{
                            "ce:given-name": "Sepehr",
                            "preferred-name": {
                                "ce:given-name": "Sepehr",
                                "ce:initials": "S.",
                                "ce:surname": "Shakib",
                                "ce:indexed-name": "Shakib S."
                            },
                            "@seq": "2",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Shakib",
                            "@auid": "7004672081",
                            "ce:indexed-name": "Shakib S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60012718",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Tropical Pediatrics"},
                                {"$": "Faculty of Tropical Medicine"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60012718",
                                "@dptid": "103674652"
                            },
                            "ce:source-text": "3Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand",
                            "@dptid": "103674652"
                        },
                        "author": [{
                            "ce:given-name": "Pornthep",
                            "preferred-name": {
                                "ce:given-name": "Pornthep",
                                "ce:initials": "P.",
                                "ce:surname": "Chanthavanich",
                                "ce:indexed-name": "Chanthavanich P."
                            },
                            "@seq": "3",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chanthavanich",
                            "@auid": "7003615177",
                            "ce:indexed-name": "Chanthavanich P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60031806",
                            "@date-locked": "2020-12-03T07:01:57.575",
                            "@country": "aus",
                            "city": "Subiaco",
                            "organization": [
                                {"$": "Division of Paediatrics"},
                                {"$": "School of Medicine"},
                                {"$": "University of Western Australia"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60031806",
                                    "@dptid": "118809518"
                                },
                                {"@afid": "60189720"}
                            ],
                            "state": "WA",
                            "ce:source-text": "4Division of Paediatrics, School of Medicine, University of Western Australia, Subiaco, WA, Australia",
                            "@dptid": "118809518"
                        },
                        "author": [{
                            "ce:given-name": "Peter",
                            "preferred-name": {
                                "ce:given-name": "Peter",
                                "ce:initials": "P.",
                                "ce:surname": "Richmond",
                                "ce:indexed-name": "Richmond P."
                            },
                            "@seq": "4",
                            "ce:initials": "P.",
                            "@date-locked": "2022-02-16T04:06:59.822",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Richmond",
                            "@auid": "57217840265",
                            "ce:indexed-name": "Richmond P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "100388806",
                            "@country": "usa",
                            "city": "St. Louis",
                            "organization": {"$": "Mercy Health Research"},
                            "affiliation-id": {"@afid": "100388806"},
                            "state": "MO",
                            "ce:source-text": "5Mercy Health Research, St. Louis, Missouri, USA"
                        },
                        "author": [{
                            "ce:given-name": "Timothy",
                            "preferred-name": {
                                "ce:given-name": "Timothy",
                                "ce:initials": "T.",
                                "ce:surname": "Smith",
                                "ce:indexed-name": "Smith T."
                            },
                            "@seq": "5",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Smith",
                            "@auid": "58444704800",
                            "ce:indexed-name": "Smith T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "ce:source-text": "6Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Terapong",
                            "preferred-name": {
                                "ce:given-name": "Terapong",
                                "ce:initials": "T.",
                                "ce:surname": "Tantawichien",
                                "ce:indexed-name": "Tantawichien T."
                            },
                            "@seq": "6",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tantawichien",
                            "@auid": "6701433574",
                            "ce:indexed-name": "Tantawichien T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Germany",
                            "@afid": "122642954",
                            "@country": "deu",
                            "city": "Marburg",
                            "organization": {"$": "GlaxoSmithKline Vaccines GmbH"},
                            "affiliation-id": {"@afid": "122642954"},
                            "ce:source-text": "7GlaxoSmithKline Vaccines GmbH, Marburg, Germany"
                        },
                        "author": [
                            {
                                "ce:given-name": "Claudia",
                                "preferred-name": {
                                    "ce:given-name": "Claudia",
                                    "ce:initials": "C.",
                                    "ce:surname": "Kittel",
                                    "ce:indexed-name": "Kittel C."
                                },
                                "@seq": "7",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kittel",
                                "@auid": "55821198600",
                                "ce:indexed-name": "Kittel C."
                            },
                            {
                                "ce:given-name": "Peter",
                                "preferred-name": {
                                    "ce:given-name": "Peter",
                                    "ce:initials": "P.",
                                    "ce:surname": "Jaehnig",
                                    "ce:indexed-name": "Jaehnig P."
                                },
                                "@seq": "8",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Jaehnig",
                                "@auid": "57190978421",
                                "ce:indexed-name": "Jaehnig P."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60111449",
                            "@country": "sgp",
                            "city": "Singapore",
                            "organization": {"$": "GlaxoSmithKline Pte Ltd."},
                            "affiliation-id": {"@afid": "60111449"},
                            "ce:source-text": "8GlaxoSmithKline Pte Ltd., Singapore, Singapore"
                        },
                        "author": [{
                            "ce:given-name": "Zenaida",
                            "preferred-name": {
                                "ce:given-name": "Zenaida",
                                "ce:initials": "Z.",
                                "ce:surname": "Mojares",
                                "ce:indexed-name": "Mojares Z."
                            },
                            "@seq": "9",
                            "ce:initials": "Z.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Mojares",
                            "@auid": "57202792507",
                            "ce:indexed-name": "Mojares Z."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60097308",
                            "@country": "usa",
                            "city": "Rockville",
                            "organization": {"$": "GlaxoSmithKline Vaccines LLC"},
                            "affiliation-id": {"@afid": "60097308"},
                            "state": "MD",
                            "ce:source-text": "9GlaxoSmithKline Vaccines LLC, Rockville, Maryland, USA"
                        },
                        "author": [
                            {
                                "ce:given-name": "Bikash",
                                "preferred-name": {
                                    "ce:given-name": "Bikash",
                                    "ce:initials": "B.",
                                    "ce:surname": "Verma",
                                    "ce:indexed-name": "Verma B."
                                },
                                "@seq": "10",
                                "ce:initials": "B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Verma",
                                "@auid": "56545214000",
                                "ce:indexed-name": "Verma B."
                            },
                            {
                                "ce:given-name": "Niranjan",
                                "preferred-name": {
                                    "ce:given-name": "Niranjan",
                                    "ce:initials": "N.",
                                    "ce:surname": "Kanesa-Thasan",
                                    "ce:indexed-name": "Kanesa-Thasan N."
                                },
                                "@seq": "11",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kanesa-Thasan",
                                "@auid": "6701428998",
                                "ce:indexed-name": "Kanesa-Thasan N."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "address-part": "50 Hampshire Street",
                            "postal-code": "02139",
                            "@afid": "117807786",
                            "@country": "usa",
                            "city": "Cambridge",
                            "organization": {"$": "Seqirus Inc."},
                            "affiliation-id": {"@afid": "117807786"},
                            "state": "MA",
                            "ce:source-text": "10Seqirus Inc., 50 Hampshire Street, Cambridge, MA 02139, USA"
                        },
                        "author": [{
                            "ce:given-name": "Matthew",
                            "preferred-name": {
                                "ce:given-name": "Matthew",
                                "ce:initials": "M.",
                                "ce:surname": "Hohenboken",
                                "ce:indexed-name": "Hohenboken M."
                            },
                            "@seq": "12",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Hohenboken",
                            "@auid": "6507554857",
                            "ce:indexed-name": "Hohenboken M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "122643050",
                            "@country": "usa",
                            "city": "St. Peters",
                            "organization": [
                                {"$": "StudyMetrix Research"},
                                {"$": "LLC"}
                            ],
                            "affiliation-id": {"@afid": "122643050"},
                            "state": "MO",
                            "ce:source-text": "11StudyMetrix Research, LLC, St. Peters, Missouri, USA"
                        },
                        "author": [{
                            "ce:given-name": "Timothy",
                            "preferred-name": {
                                "ce:given-name": "Timothy",
                                "ce:initials": "T.",
                                "ce:surname": "Smith",
                                "ce:indexed-name": "Smith T."
                            },
                            "@seq": "5",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Smith",
                            "@auid": "58444704800",
                            "ce:indexed-name": "Smith T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Germany",
                            "@afid": "115052134",
                            "@country": "deu",
                            "city": "Berlin",
                            "organization": {"$": "PJ Statistics"},
                            "affiliation-id": {"@afid": "115052134"},
                            "ce:source-text": "12PJ Statistics, Berlin, Germany"
                        },
                        "author": [{
                            "ce:given-name": "Peter",
                            "preferred-name": {
                                "ce:given-name": "Peter",
                                "ce:initials": "P.",
                                "ce:surname": "Jaehnig",
                                "ce:indexed-name": "Jaehnig P."
                            },
                            "@seq": "8",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Jaehnig",
                            "@auid": "57190978421",
                            "ce:indexed-name": "Jaehnig P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Switzerland",
                            "@afid": "60113339",
                            "@country": "che",
                            "city": "Zurich",
                            "organization": {"$": "Takeda Pharmaceuticals International AG"},
                            "affiliation-id": {"@afid": "60113339"},
                            "ce:source-text": "13Takeda Pharmaceuticals International AG, Zurich, Switzerland"
                        },
                        "author": [{
                            "ce:given-name": "Zenaida",
                            "preferred-name": {
                                "ce:given-name": "Zenaida",
                                "ce:initials": "Z.",
                                "ce:surname": "Mojares",
                                "ce:indexed-name": "Mojares Z."
                            },
                            "@seq": "9",
                            "ce:initials": "Z.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Mojares",
                            "@auid": "57202792507",
                            "ce:indexed-name": "Mojares Z."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "120805248",
                            "@country": "usa",
                            "city": "Lexington",
                            "organization": [
                                {"$": "Kanesa"},
                                {"$": "LLC"}
                            ],
                            "affiliation-id": {"@afid": "120805248"},
                            "state": "MA",
                            "ce:source-text": "14Kanesa, LLC, Lexington, Massachusetts, USA"
                        },
                        "author": [{
                            "ce:given-name": "Niranjan",
                            "preferred-name": {
                                "ce:given-name": "Niranjan",
                                "ce:initials": "N.",
                                "ce:surname": "Kanesa-Thasan",
                                "ce:indexed-name": "Kanesa-Thasan N."
                            },
                            "@seq": "11",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kanesa-Thasan",
                            "@auid": "6701428998",
                            "ce:indexed-name": "Kanesa-Thasan N."
                        }]
                    }
                ],
                "citation-title": "Safety and immunogenicity of MF59-adjuvanted cell culture-derived A/H5N1 subunit influenza virus vaccine: Dose-finding clinical trials in adults and the elderly",
                "abstracts": "© The Author(s) 2019.Background. A/H5N1 influenza viruses have high pandemic potential; consequently, vaccines need to be produced rapidly. MF59® adjuvant reduces the antigen required per dose, allowing for dose sparing and more rapid vaccine availability. Methods. Two multicenter, phase II trials were conducted to evaluate the safety and immunogenicity of an MF59-adjuvanted, cell culture-derived, A/H5N1 vaccine (aH5N1c) among 979 adult (18-64 years old) and 1393 elderly (≥65 years old) subjects. Participants were equally randomized to receive 2 full-dose (7.5 μg of hemagglutinin antigen per dose) or 2 half-dose aH5N1c vaccinations 3 weeks apart. Outcomes were based on Center for Biologics Evaluation Research and Review (CBER) and Committee for Medicinal Products for Human Use (CHMP) licensure criteria (titers ≥1:40 and seroconversions on day 43). Solicited reactions and adverse events were assessed (www.clinicaltrials.gov: NCT01776541 and NCT01766921). Results. CBER and CHMP criteria were met by both age groups. CBER criteria for hemagglutination titers were met for the fulldose formulation. Solicited reaction frequencies tended to be higher in the full-dose group and were of mild to moderate intensity. No vaccine-related serious adverse events occurred. Conclusions. In adult and elderly participants, the full-dose aH5N1c vaccine formulation was well tolerated and met US and European licensure criteria for pandemic vaccines.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "address-part": "50 Hampshire Street",
                        "postal-code": "02139",
                        "@country": "usa",
                        "city": "Cambridge",
                        "organization": {"$": "Seqirus Inc."},
                        "state": "MA",
                        "ce:source-text": "Seqirus Inc., 50 Hampshire Street, Cambridge, MA 02139, USA"
                    },
                    "person": {
                        "ce:given-name": "Matthew",
                        "ce:initials": "M.",
                        "ce:surname": "Hohenboken",
                        "ce:indexed-name": "Hohenboken M."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "cell culture-derived vaccine",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "H5N1 subunit vaccine",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "influenza",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "MF59 adjuvant",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "pandemic influenza",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "phase II",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://academic.oup.com/ofid",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "volisspag": {"voliss": {
                        "@volume": "6",
                        "@issue": "4"
                    }},
                    "@type": "j",
                    "sourcetitle": "Open Forum Infectious Diseases",
                    "publicationdate": {
                        "month": "04",
                        "year": "2019",
                        "date-text": "April 2019",
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "Open Forum Infect. Dis.",
                    "@country": "usa",
                    "issn": {
                        "$": "23288957",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2019"},
                    "publisher": {
                        "publishername": "Oxford University Press",
                        "ce:e-address": {
                            "$": "info@idsociety.org",
                            "@type": "email"
                        }
                    },
                    "article-number": "ofz107",
                    "@srcid": "21100468501"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "26",
                                    "classification-description": "Immunology, Serology and Transplantation"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "4",
                                    "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2730"},
                                {"$": "2725"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": {
                            "cas-registry-number": "83461-56-7",
                            "chemical-name": "mifamurtide"
                        }
                    }},
                    "manufacturergroup": {"manufacturers": {
                        "@type": "MNF",
                        "manufacturer": {
                            "@country": "deu",
                            "$": "Novartis Influenza Vaccines"
                        }
                    }}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2019 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "08",
                    "@year": "2019",
                    "@timestamp": "BST 05:37:41",
                    "@month": "06"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "627904524",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "917780477",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20190371652",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "2019171411",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20191022350",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2019163562",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20191546657",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85066395588",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85066395588",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.1093/ofid/ofz107"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "28",
                "reference": [
                    {
                        "ref-fulltext": "World Health Organization. Avian influenza fact sheet. 2014. http://www.who. int/mediacentre/factsheets/avian_influenza/en/. Accessed November 2015.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.who.int/mediacentre/factsheets/avian_influenza/en/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84930589354",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization. Accessed November 2015.",
                            "ref-sourcetitle": "Avian Influenza Fact Sheet"
                        },
                        "ce:source-text": "World Health Organization. Avian influenza fact sheet. 2014. http://www.who. int/mediacentre/factsheets/avian_influenza/en/. Accessed November 2015."
                    },
                    {
                        "ref-fulltext": "Zaman M, Gasimov V, Oner AF, et al. Recognizing true H5N1 infections in humans during confirmed outbreaks. J Infect Dev Ctries 2014; 8:202-7.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Recognizing true H5N1 infections in humans during confirmed outbreaks"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84893907083",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "202",
                                    "@last": "207"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Zaman",
                                        "ce:indexed-name": "Zaman M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Gasimov",
                                        "ce:indexed-name": "Gasimov V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Oner",
                                        "ce:indexed-name": "Oner A.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Infect Dev Ctries"
                        },
                        "ce:source-text": "Zaman M, Gasimov V, Oner AF, et al. Recognizing true H5N1 infections in humans during confirmed outbreaks. J Infect Dev Ctries 2014; 8:202-7."
                    },
                    {
                        "ref-fulltext": "World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2015. 2015. http:// www.who.int/influenza/human_animal_interface/EN_GIP_20150106 CumulativeNumberH5N1cases.pdf?ua=1. Accessed November 2015.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.who.int/influenza/human_animal_interface/EN_GIP_20150106CumulativeNumberH5N1cases.pdf?ua=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "33645421057",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization. Accessed November 2015.",
                            "ref-sourcetitle": "Cumulative Number of Confirmed Human Cases for Avian Influenza A(H5N1) Reported to WHO, 2003-2015"
                        },
                        "ce:source-text": "World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2015. 2015. http:// www.who.int/influenza/human_animal_interface/EN_GIP_20150106 CumulativeNumberH5N1cases.pdf?ua=1. Accessed November 2015."
                    },
                    {
                        "ref-fulltext": "World Health Organization. Pandemic influenza risk management WHO interim guidance June 2013. 2013. http://www.who.int/influenza/preparedness/pandemic/ GIP_PandemicInfluenzaRiskManagementInterimGuidance_Jun2013. pdf?ua=1. Accessed November 2015.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.who.int/influenza/preparedness/pandemic/GIP_PandemicInfluenzaRiskManagementInterimGuidance_Jun2013.pdf?ua=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84880314874",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization. Accessed November 2015.",
                            "ref-sourcetitle": "Pandemic Influenza Risk Management WHO Interim Guidance June 2013"
                        },
                        "ce:source-text": "World Health Organization. Pandemic influenza risk management WHO interim guidance June 2013. 2013. http://www.who.int/influenza/preparedness/pandemic/ GIP_PandemicInfluenzaRiskManagementInterimGuidance_Jun2013. pdf?ua=1. Accessed November 2015."
                    },
                    {
                        "ref-fulltext": "Rappuoli R, Dormitzer PR. Influenza: Options to improve pandemic preparation. Science 2012; 336:1531-3.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Influenza: Options to improve pandemic preparation"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84862604774",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "336"},
                                "pagerange": {
                                    "@first": "1531",
                                    "@last": "1533"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Rappuoli",
                                    "ce:indexed-name": "Rappuoli R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Dormitzer",
                                    "ce:indexed-name": "Dormitzer P.R."
                                }
                            ]},
                            "ref-sourcetitle": "Science"
                        },
                        "ce:source-text": "Rappuoli R, Dormitzer PR. Influenza: Options to improve pandemic preparation. Science 2012; 336:1531-3."
                    },
                    {
                        "ref-fulltext": "Hatz C, Cramer JP, Vertruyen A, et al. A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations. Vaccine 2012; 30:4820-7.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84862524027",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "4820",
                                    "@last": "4827"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Hatz",
                                        "ce:indexed-name": "Hatz C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Cramer",
                                        "ce:indexed-name": "Cramer J.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Vertruyen",
                                        "ce:indexed-name": "Vertruyen A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Hatz C, Cramer JP, Vertruyen A, et al. A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations. Vaccine 2012; 30:4820-7."
                    },
                    {
                        "ref-fulltext": "Pellegrini M, Nicolay U, Lindert K, et al. MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database. Vaccine 2009; 27:6959-65.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database"},
                            "refd-itemidlist": {"itemid": {
                                "$": "70350581274",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "6959",
                                    "@last": "6965"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Pellegrini",
                                        "ce:indexed-name": "Pellegrini M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "U.",
                                        "@_fa": "true",
                                        "ce:surname": "Nicolay",
                                        "ce:indexed-name": "Nicolay U."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Lindert",
                                        "ce:indexed-name": "Lindert K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Pellegrini M, Nicolay U, Lindert K, et al. MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database. Vaccine 2009; 27:6959-65."
                    },
                    {
                        "ref-fulltext": "Banzhoff A, Gasparini R, Laghi-Pasini F, et al. MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. PLoS One 2009; 4:e4384.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84887212536",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {"@first": "e4384"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Banzhoff",
                                        "ce:indexed-name": "Banzhoff A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Gasparini",
                                        "ce:indexed-name": "Gasparini R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Laghi-Pasini",
                                        "ce:indexed-name": "Laghi-Pasini F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Banzhoff A, Gasparini R, Laghi-Pasini F, et al. MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. PLoS One 2009; 4:e4384."
                    },
                    {
                        "ref-fulltext": "Bernstein DI, Edwards KM, Dekker CL, et al. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults. J Infect Dis 2008; 197:667-75.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults"},
                            "refd-itemidlist": {"itemid": {
                                "$": "40549088240",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "197"},
                                "pagerange": {
                                    "@first": "667",
                                    "@last": "675"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Bernstein",
                                        "ce:indexed-name": "Bernstein D.I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Edwards",
                                        "ce:indexed-name": "Edwards K.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Dekker",
                                        "ce:indexed-name": "Dekker C.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Infect Dis"
                        },
                        "ce:source-text": "Bernstein DI, Edwards KM, Dekker CL, et al. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults. J Infect Dis 2008; 197:667-75."
                    },
                    {
                        "ref-fulltext": "Leroux-Roels I, Borkowski A, Vanwolleghem T, et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: A randomised controlled trial. Lancet 2007; 370:580-9.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: A randomised controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34547837401",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "370"},
                                "pagerange": {
                                    "@first": "580",
                                    "@last": "589"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Leroux-Roels",
                                        "ce:indexed-name": "Leroux-Roels I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Borkowski",
                                        "ce:indexed-name": "Borkowski A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Vanwolleghem",
                                        "ce:indexed-name": "Vanwolleghem T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Leroux-Roels I, Borkowski A, Vanwolleghem T, et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: A randomised controlled trial. Lancet 2007; 370:580-9."
                    },
                    {
                        "ref-fulltext": "Galli G, Hancock K, Hoschler K, et al. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc Natl Acad Sci U S A 2009; 106:7962-7.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine"},
                            "refd-itemidlist": {"itemid": {
                                "$": "66049086576",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "106"},
                                "pagerange": {
                                    "@first": "7962",
                                    "@last": "7967"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Galli",
                                        "ce:indexed-name": "Galli G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Hancock",
                                        "ce:indexed-name": "Hancock K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Hoschler",
                                        "ce:indexed-name": "Hoschler K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Proc Natl Acad Sci U S A"
                        },
                        "ce:source-text": "Galli G, Hancock K, Hoschler K, et al. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc Natl Acad Sci U S A 2009; 106:7962-7."
                    },
                    {
                        "ref-fulltext": "Stephenson I, Nicholson KG, Hoschler K, et al. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. N Engl J Med 2008; 359:1631-3.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1"},
                            "refd-itemidlist": {"itemid": {
                                "$": "53749098101",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "359"},
                                "pagerange": {
                                    "@first": "1631",
                                    "@last": "1633"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Stephenson",
                                        "ce:indexed-name": "Stephenson I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Nicholson",
                                        "ce:indexed-name": "Nicholson K.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Hoschler",
                                        "ce:indexed-name": "Hoschler K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Stephenson I, Nicholson KG, Hoschler K, et al. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. N Engl J Med 2008; 359:1631-3."
                    },
                    {
                        "ref-fulltext": "Van Buynder PG, Konrad S, Van Buynder JL, et al. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine 2013; 31:6122-8.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84888431662",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "6122",
                                    "@last": "6128"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Buynder",
                                        "ce:indexed-name": "Van Buynder P.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Konrad",
                                        "ce:indexed-name": "Konrad S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Buynder",
                                        "ce:indexed-name": "Van Buynder J.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Van Buynder PG, Konrad S, Van Buynder JL, et al. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine 2013; 31:6122-8."
                    },
                    {
                        "ref-fulltext": "Keitel W, Groth N, Lattanzi M, et al. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase clinical trial. Vaccine 2010; 28:840-8.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase clinical trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "71349088027",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "840",
                                    "@last": "848"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Keitel",
                                        "ce:indexed-name": "Keitel W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Groth",
                                        "ce:indexed-name": "Groth N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Lattanzi",
                                        "ce:indexed-name": "Lattanzi M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Keitel W, Groth N, Lattanzi M, et al. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase clinical trial. Vaccine 2010; 28:840-8."
                    },
                    {
                        "ref-fulltext": "Belshe RB, Frey SE, Graham IL, et al. Immunogenicity of avian influenza A/ Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: A randomized clinical trial. JAMA 2014; 312:1420-8.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Immunogenicity of avian influenza A/ Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: A randomized clinical trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84907704195",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "312"},
                                "pagerange": {
                                    "@first": "1420",
                                    "@last": "1428"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Belshe",
                                        "ce:indexed-name": "Belshe R.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Frey",
                                        "ce:indexed-name": "Frey S.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Graham",
                                        "ce:indexed-name": "Graham I.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA"
                        },
                        "ce:source-text": "Belshe RB, Frey SE, Graham IL, et al. Immunogenicity of avian influenza A/ Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: A randomized clinical trial. JAMA 2014; 312:1420-8."
                    },
                    {
                        "ref-fulltext": "Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for industry: Clinical data needed to support the licensure of pandemic influenza vaccines. 2007. http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm074786. htm. Accessed November 2015.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm074786.htm",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "64549114375",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Food and Drug Administration, Center for Biologics Evaluation and Research. Accessed November 2015.",
                            "ref-sourcetitle": "Guidance for Industry: Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines"
                        },
                        "ce:source-text": "Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for industry: Clinical data needed to support the licensure of pandemic influenza vaccines. 2007. http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm074786. htm. Accessed November 2015."
                    },
                    {
                        "ref-fulltext": "European Committee for Proprietary Medicinal Products. Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96). 1997. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2009/09/WC500003945.pdf. Accessed November 2015.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1997"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "0003771029",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "European Committee for Proprietary Medicinal Products. Accessed November 2015.",
                            "ref-sourcetitle": "Note for Guidance on Harmonisation of Requirements for Influenza Vaccines (CPMP/BWP/214/96)"
                        },
                        "ce:source-text": "European Committee for Proprietary Medicinal Products. Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96). 1997. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2009/09/WC500003945.pdf. Accessed November 2015."
                    },
                    {
                        "ref-fulltext": "Czajka H, Unal S, Ulusoy S, et al. A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. J Prev Med Hyg 2012; 53:136-42.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84868124432",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "53"},
                                "pagerange": {
                                    "@first": "136",
                                    "@last": "142"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Czajka",
                                        "ce:indexed-name": "Czajka H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Unal",
                                        "ce:indexed-name": "Unal S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ulusoy",
                                        "ce:indexed-name": "Ulusoy S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Prev Med Hyg"
                        },
                        "ce:source-text": "Czajka H, Unal S, Ulusoy S, et al. A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. J Prev Med Hyg 2012; 53:136-42."
                    },
                    {
                        "ref-fulltext": "Vesikari T, Forsten A, Herbinger KH, et al. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly. Vaccine 2012; 30:1388-96.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84856564196",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "1388",
                                    "@last": "1396"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Vesikari",
                                        "ce:indexed-name": "Vesikari T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Forsten",
                                        "ce:indexed-name": "Forsten A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Herbinger",
                                        "ce:indexed-name": "Herbinger K.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Vesikari T, Forsten A, Herbinger KH, et al. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly. Vaccine 2012; 30:1388-96."
                    },
                    {
                        "ref-fulltext": "Johnson C, Hohenboken M, Poling T, et al. Safety and immunogenicity of cell culture-derived A/H3N2 variant influenza vaccines: A phase I randomized, observer-blind, dose-ranging study. J Infect Dis 2015; 212:72-80.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Safety and immunogenicity of cell culture-derived A/H3N2 variant influenza vaccines: A phase I randomized, observer-blind, dose-ranging study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84936751055",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "212"},
                                "pagerange": {
                                    "@first": "72",
                                    "@last": "80"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Johnson",
                                        "ce:indexed-name": "Johnson C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Hohenboken",
                                        "ce:indexed-name": "Hohenboken M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Poling",
                                        "ce:indexed-name": "Poling T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Infect Dis"
                        },
                        "ce:source-text": "Johnson C, Hohenboken M, Poling T, et al. Safety and immunogenicity of cell culture-derived A/H3N2 variant influenza vaccines: A phase I randomized, observer-blind, dose-ranging study. J Infect Dis 2015; 212:72-80."
                    },
                    {
                        "ref-fulltext": "Fukase H, Furuie H, Yasuda Y, et al. Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects. Vaccine 2012; 30:5030-7.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84862753466",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "5030",
                                    "@last": "5037"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Fukase",
                                        "ce:indexed-name": "Fukase H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Furuie",
                                        "ce:indexed-name": "Furuie H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yasuda",
                                        "ce:indexed-name": "Yasuda Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Fukase H, Furuie H, Yasuda Y, et al. Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects. Vaccine 2012; 30:5030-7."
                    },
                    {
                        "ref-fulltext": "Hatz C, von Sonnenburg F, Casula D, et al. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. Vaccine 2012; 30:3470-7.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84859814732",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "3470",
                                    "@last": "3477"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Hatz",
                                        "ce:indexed-name": "Hatz C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Von Sonnenburg",
                                        "ce:indexed-name": "Von Sonnenburg F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Casula",
                                        "ce:indexed-name": "Casula D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Hatz C, von Sonnenburg F, Casula D, et al. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. Vaccine 2012; 30:3470-7."
                    },
                    {
                        "ref-fulltext": "Knuf M, Leroux-Roels G, Rumke H, et al. Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children. Hum Vaccin Immunother 2015; 11:358-76.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84929082192",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "358",
                                    "@last": "376"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Knuf",
                                        "ce:indexed-name": "Knuf M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Leroux-Roels",
                                        "ce:indexed-name": "Leroux-Roels G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Rumke",
                                        "ce:indexed-name": "Rumke H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hum Vaccin Immunother"
                        },
                        "ce:source-text": "Knuf M, Leroux-Roels G, Rumke H, et al. Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children. Hum Vaccin Immunother 2015; 11:358-76."
                    },
                    {
                        "ref-fulltext": "Knuf M, Leroux-Roels G, Rumke HC, et al. Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age. Pediatr Infect Dis J 2014; 33:e320-9.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84926215593",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "e320",
                                    "@last": "e329"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Knuf",
                                        "ce:indexed-name": "Knuf M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Leroux-Roels",
                                        "ce:indexed-name": "Leroux-Roels G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Rumke",
                                        "ce:indexed-name": "Rumke H.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pediatr Infect Dis J"
                        },
                        "ce:source-text": "Knuf M, Leroux-Roels G, Rumke HC, et al. Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age. Pediatr Infect Dis J 2014; 33:e320-9."
                    },
                    {
                        "ref-fulltext": "Knuf M, Leroux-Roels G, Rumke HC, et al. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age. Vaccine 2015; 33:174-81.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84919372178",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "174",
                                    "@last": "181"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Knuf",
                                        "ce:indexed-name": "Knuf M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Leroux-Roels",
                                        "ce:indexed-name": "Leroux-Roels G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Rumke",
                                        "ce:indexed-name": "Rumke H.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Knuf M, Leroux-Roels G, Rumke HC, et al. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age. Vaccine 2015; 33:174-81."
                    },
                    {
                        "ref-fulltext": "Nassim C, Christensen S, Henry D, et al. Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. Pediatr Infect Dis J 2012; 31:e59-65.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84858767551",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "e59",
                                    "@last": "e65"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Nassim",
                                        "ce:indexed-name": "Nassim C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Christensen",
                                        "ce:indexed-name": "Christensen S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Henry",
                                        "ce:indexed-name": "Henry D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pediatr Infect Dis J"
                        },
                        "ce:source-text": "Nassim C, Christensen S, Henry D, et al. Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. Pediatr Infect Dis J 2012; 31:e59-65."
                    },
                    {
                        "ref-fulltext": "Reisinger KS, Holmes SJ, Pedotti P, et al. A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination. Hum Vaccin Immunother 2014; 10:2395-407.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84908459780",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "2395",
                                    "@last": "2407"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Reisinger",
                                        "ce:indexed-name": "Reisinger K.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Holmes",
                                        "ce:indexed-name": "Holmes S.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Pedotti",
                                        "ce:indexed-name": "Pedotti P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hum Vaccin Immunother"
                        },
                        "ce:source-text": "Reisinger KS, Holmes SJ, Pedotti P, et al. A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination. Hum Vaccin Immunother 2014; 10:2395-407."
                    },
                    {
                        "ref-fulltext": "Yasuda Y, Komatsu R, Matsushita K, et al. Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children. Adv Ther 2010; 27:444-57.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77956230638",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "444",
                                    "@last": "457"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yasuda",
                                        "ce:indexed-name": "Yasuda Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Komatsu",
                                        "ce:indexed-name": "Komatsu R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Matsushita",
                                        "ce:indexed-name": "Matsushita K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Adv Ther"
                        },
                        "ce:source-text": "Yasuda Y, Komatsu R, Matsushita K, et al. Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children. Adv Ther 2010; 27:444-57."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Zurich",
            "@id": "60113339",
            "affilname": "Takeda Pharma AG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60113339",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60111449",
            "affilname": "GlaxoSmithKline, Singapore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111449",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60097308",
            "affilname": "GlaxoSmithKline, USA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60097308",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Perth",
            "@id": "60031806",
            "affilname": "The University of Western Australia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031806",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "St. Louis",
            "@id": "60028590",
            "affilname": "Saint Louis University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028590",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "St Peters",
            "@id": "122643050",
            "affilname": "StudyMetrix Research",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122643050",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Marburg",
            "@id": "122642954",
            "affilname": "GlaxoSmithKline Vaccines",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122642954",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Adelaide",
            "@id": "122642906",
            "affilname": "CMAX Clinical Research Pty Ltd",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122642906",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Lexington",
            "@id": "120805248",
            "affilname": "Kanesa LLC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120805248",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Cambridge",
            "@id": "117807786",
            "affilname": "Seqirus Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117807786",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Berlin",
            "@id": "115052134",
            "affilname": "pj statistics",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/115052134",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "St Louis",
            "@id": "100388806",
            "affilname": "Mercy Health Research",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100388806",
            "affiliation-country": "United States"
        }
    ],
    "coredata": {
        "srctype": "j",
        "prism:issueIdentifier": "4",
        "eid": "2-s2.0-85066395588",
        "dc:description": "Background. A/H5N1 influenza viruses have high pandemic potential; consequently, vaccines need to be produced rapidly. MF59® adjuvant reduces the antigen required per dose, allowing for dose sparing and more rapid vaccine availability. Methods. Two multicenter, phase II trials were conducted to evaluate the safety and immunogenicity of an MF59-adjuvanted, cell culture-derived, A/H5N1 vaccine (aH5N1c) among 979 adult (18-64 years old) and 1393 elderly (≥65 years old) subjects. Participants were equally randomized to receive 2 full-dose (7.5 μg of hemagglutinin antigen per dose) or 2 half-dose aH5N1c vaccinations 3 weeks apart. Outcomes were based on Center for Biologics Evaluation Research and Review (CBER) and Committee for Medicinal Products for Human Use (CHMP) licensure criteria (titers ≥1:40 and seroconversions on day 43). Solicited reactions and adverse events were assessed (www.clinicaltrials.gov: NCT01776541 and NCT01766921). Results. CBER and CHMP criteria were met by both age groups. CBER criteria for hemagglutination titers were met for the fulldose formulation. Solicited reaction frequencies tended to be higher in the full-dose group and were of mild to moderate intensity. No vaccine-related serious adverse events occurred. Conclusions. In adult and elderly participants, the full-dose aH5N1c vaccine formulation was well tolerated and met US and European licensure criteria for pandemic vaccines.",
        "prism:coverDate": "2019-04-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85066395588",
        "subtypeDescription": "Article",
        "dc:creator": {"author": [{
            "ce:given-name": "Sharon E.",
            "preferred-name": {
                "ce:given-name": "Sharon E.",
                "ce:initials": "S.E.",
                "ce:surname": "Frey",
                "ce:indexed-name": "Frey S.E."
            },
            "@seq": "1",
            "ce:initials": "S.E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028590",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028590"
            },
            "ce:surname": "Frey",
            "@auid": "34975079200",
            "author-url": "https://api.elsevier.com/content/author/author_id/34975079200",
            "ce:indexed-name": "Frey S.E."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85066395588"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066395588&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85066395588&origin=inward"
            }
        ],
        "prism:publicationName": "Open Forum Infectious Diseases",
        "source-id": "21100468501",
        "citedby-count": "7",
        "prism:volume": "6",
        "subtype": "ar",
        "dc:title": "Safety and immunogenicity of MF59-adjuvanted cell culture-derived A/H5N1 subunit influenza virus vaccine: Dose-finding clinical trials in adults and the elderly",
        "openaccess": "1",
        "openaccessFlag": "true",
        "prism:doi": "10.1093/ofid/ofz107",
        "prism:issn": "23288957",
        "publishercopyright": "© The Author(s) 2019.",
        "article-number": "ofz107",
        "dc:identifier": "SCOPUS_ID:85066395588",
        "dc:publisher": "Oxford University Pressinfo@idsociety.org"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "cell culture-derived vaccine"
        },
        {
            "@_fa": "true",
            "$": "H5N1 subunit vaccine"
        },
        {
            "@_fa": "true",
            "$": "influenza"
        },
        {
            "@_fa": "true",
            "$": "MF59 adjuvant"
        },
        {
            "@_fa": "true",
            "$": "pandemic influenza"
        },
        {
            "@_fa": "true",
            "$": "phase II"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Sharon E.",
            "preferred-name": {
                "ce:given-name": "Sharon E.",
                "ce:initials": "S.E.",
                "ce:surname": "Frey",
                "ce:indexed-name": "Frey S.E."
            },
            "@seq": "1",
            "ce:initials": "S.E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028590",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028590"
            },
            "ce:surname": "Frey",
            "@auid": "34975079200",
            "author-url": "https://api.elsevier.com/content/author/author_id/34975079200",
            "ce:indexed-name": "Frey S.E."
        },
        {
            "ce:given-name": "Sepehr",
            "preferred-name": {
                "ce:given-name": "Sepehr",
                "ce:initials": "S.",
                "ce:surname": "Shakib",
                "ce:indexed-name": "Shakib S."
            },
            "@seq": "2",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "122642906",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122642906"
            },
            "ce:surname": "Shakib",
            "@auid": "7004672081",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004672081",
            "ce:indexed-name": "Shakib S."
        },
        {
            "ce:given-name": "Pornthep",
            "preferred-name": {
                "ce:given-name": "Pornthep",
                "ce:initials": "P.",
                "ce:surname": "Chanthavanich",
                "ce:indexed-name": "Chanthavanich P."
            },
            "@seq": "3",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012718",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"
            },
            "ce:surname": "Chanthavanich",
            "@auid": "7003615177",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003615177",
            "ce:indexed-name": "Chanthavanich P."
        },
        {
            "ce:given-name": "Peter",
            "preferred-name": {
                "ce:given-name": "Peter",
                "ce:initials": "P.",
                "ce:surname": "Richmond",
                "ce:indexed-name": "Richmond P."
            },
            "@seq": "4",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031806",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031806"
            },
            "ce:surname": "Richmond",
            "@auid": "57217840265",
            "author-url": "https://api.elsevier.com/content/author/author_id/57217840265",
            "ce:indexed-name": "Richmond P."
        },
        {
            "ce:given-name": "Timothy",
            "preferred-name": {
                "ce:given-name": "Timothy",
                "ce:initials": "T.",
                "ce:surname": "Smith",
                "ce:indexed-name": "Smith T."
            },
            "@seq": "5",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "100388806",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100388806"
                },
                {
                    "@id": "122643050",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122643050"
                }
            ],
            "ce:surname": "Smith",
            "@auid": "58444704800",
            "author-url": "https://api.elsevier.com/content/author/author_id/58444704800",
            "ce:indexed-name": "Smith T."
        },
        {
            "ce:given-name": "Terapong",
            "preferred-name": {
                "ce:given-name": "Terapong",
                "ce:initials": "T.",
                "ce:surname": "Tantawichien",
                "ce:indexed-name": "Tantawichien T."
            },
            "@seq": "6",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Tantawichien",
            "@auid": "6701433574",
            "author-url": "https://api.elsevier.com/content/author/author_id/6701433574",
            "ce:indexed-name": "Tantawichien T."
        },
        {
            "ce:given-name": "Claudia",
            "preferred-name": {
                "ce:given-name": "Claudia",
                "ce:initials": "C.",
                "ce:surname": "Kittel",
                "ce:indexed-name": "Kittel C."
            },
            "@seq": "7",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "122642954",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122642954"
            },
            "ce:surname": "Kittel",
            "@auid": "55821198600",
            "author-url": "https://api.elsevier.com/content/author/author_id/55821198600",
            "ce:indexed-name": "Kittel C."
        },
        {
            "ce:given-name": "Peter",
            "preferred-name": {
                "ce:given-name": "Peter",
                "ce:initials": "P.",
                "ce:surname": "Jaehnig",
                "ce:indexed-name": "Jaehnig P."
            },
            "@seq": "8",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "122642954",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122642954"
                },
                {
                    "@id": "115052134",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/115052134"
                }
            ],
            "ce:surname": "Jaehnig",
            "@auid": "57190978421",
            "author-url": "https://api.elsevier.com/content/author/author_id/57190978421",
            "ce:indexed-name": "Jaehnig P."
        },
        {
            "ce:given-name": "Zenaida",
            "preferred-name": {
                "ce:given-name": "Zenaida",
                "ce:initials": "Z.",
                "ce:surname": "Mojares",
                "ce:indexed-name": "Mojares Z."
            },
            "@seq": "9",
            "ce:initials": "Z.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60111449",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111449"
                },
                {
                    "@id": "60113339",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60113339"
                }
            ],
            "ce:surname": "Mojares",
            "@auid": "57202792507",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202792507",
            "ce:indexed-name": "Mojares Z."
        },
        {
            "ce:given-name": "Bikash",
            "preferred-name": {
                "ce:given-name": "Bikash",
                "ce:initials": "B.",
                "ce:surname": "Verma",
                "ce:indexed-name": "Verma B."
            },
            "@seq": "10",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60097308",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60097308"
            },
            "ce:surname": "Verma",
            "@auid": "56545214000",
            "author-url": "https://api.elsevier.com/content/author/author_id/56545214000",
            "ce:indexed-name": "Verma B."
        },
        {
            "ce:given-name": "Niranjan",
            "preferred-name": {
                "ce:given-name": "Niranjan",
                "ce:initials": "N.",
                "ce:surname": "Kanesa-Thasan",
                "ce:indexed-name": "Kanesa-Thasan N."
            },
            "@seq": "11",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60097308",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60097308"
                },
                {
                    "@id": "120805248",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120805248"
                }
            ],
            "ce:surname": "Kanesa-Thasan",
            "@auid": "6701428998",
            "author-url": "https://api.elsevier.com/content/author/author_id/6701428998",
            "ce:indexed-name": "Kanesa-Thasan N."
        },
        {
            "ce:given-name": "Matthew",
            "preferred-name": {
                "ce:given-name": "Matthew",
                "ce:initials": "M.",
                "ce:surname": "Hohenboken",
                "ce:indexed-name": "Hohenboken M."
            },
            "@seq": "12",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "117807786",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117807786"
            },
            "ce:surname": "Hohenboken",
            "@auid": "6507554857",
            "author-url": "https://api.elsevier.com/content/author/author_id/6507554857",
            "ce:indexed-name": "Hohenboken M."
        }
    ]}
}}